Nicolay V Sinackevich

Title: Nicolay V Sinackevich: Innovator in Pharmaceutical Polypeptide Compositions

Introduction

Nicolay V Sinackevich, based in St. Petersburg, Russia, is a noteworthy inventor in the field of pharmaceutical innovations. With two patents to his name, his contributions significantly enhance the understanding and treatment of immune-related conditions.

Latest Patents

Sinackevich's most recent patents include "Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof" and "Immunomodulating peptides and methods of use." The first patent offers innovative pharmaceutical compositions intended for the therapy of individuals with immunodeficient, immunodepressed, or hyperactive immune states. It utilizes peptides characterized by the formula R’-L-Glx-L-Glx-L-Lys-R’ and their pharmaceutically acceptable salts, targeting the prevention and treatment of opportunistic infections. The second patent focuses on methods of modulating the immune system through administration of specific peptides, revealing applications in the therapeutic domain by utilizing peptides such as Thr-Ala-Glu-Glu-Lys and Thr-Pro-Glu-Glu-Lys.

Career Highlights

During his career, Nicolay has worked with companies such as Cytran Incorporation and Cytran, Inc. His expertise and dedication to research have led to substantial advancements in pharmaceutical sciences, particularly in immunology.

Collaborations

Sinackevich has collaborated with esteemed professionals, including Lawrence R Green and Vadim T Ivanov. These partnerships enhance the breadth and impact of his research, driving innovation in the pharmaceutical industry.

Conclusion

Nicolay V Sinackevich exemplifies the spirit of innovation in the realm of pharmaceutical inventions. His patents serve not only as a testament to his ingenuity but also as vital resources in combating immune system-related challenges. Through his work, he continues to make significant strides in improving health outcomes for many.